EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes


Antimicrobial Agents and ChemoTherapy 38(5): 1144-1148
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit the in vitro intraerythrocytic development of Plasmodium falciparum and Babesia divergens, with concentrations inhibiting parasite growth by 50% in the ranges of 10 to 20 and 5 to 10 micro g/ml, respectively.


Accession: 002549928

PMID: 8067753

DOI: 10.1128/AAC.38.5.1144



Related references

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrobial Agents & Chemotherapy 38(5): 1144-1148, 1994

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. Bmc Cancer 8(): 9-9, 2008

In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes. Toxicology and Applied Pharmacology 131(1): 163-174, 1995

Lovastatin and simvastatin inhibitors of hydroxy methylglutaryl coenzyme a reductase and cholesterol biosynthesis. Cardiology 77(SUPPL 4): 14-21, 1990

Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. Journal of Pharmaceutical Sciences 80(9): 830-834, 1991

A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors. Leukemia & Lymphoma 24(5-6): 533-537, 1997

Relative lipophilicities solubilities and structure pharmacological considerations of 3 hydroxy 3 methylglutaryl coenzyme a hmg coa reductase inhibitors pravastatin lovastatin mevastatin simvastatin. Journal of Pharmaceutical Sciences 80(9): 830-834, 1991

Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Immunopharmacology 34(1): 51-61, 1996

Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Immunopharmacology 34(1): 51-61, 1996

Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Biochemical Pharmacology 45(11): 2203-2208, 1993